PMA: Merck Exec VP John Lyons nominated (pending board approval) as chairman-elect for 1989-1990. Lilly Exec VP Eugene Step is in line to assume chairmanship at this year's April 24-26 association annual meeting.
You may also be interested in...
Company is confident that data readout from pivotal trial could be ready before the end of 2020.
Cognoa said it will submit its AI-powered digital app for early detection of autism for de novo clearance with the US FDA. See what the company’s senior medical director of clinical adoption said about it here.
Congress should give FDA more flexibility to administer orphan designations, such as the ability to revoke designations later if the disease prevalence grows beyond the rare disease threshold.